The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.
about
The pathophysiological basis and consequences of feverConsensus statement from the 2014 International Microdialysis ForumCerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approachBioanalytical chemistry of cytokines--a reviewInflammatory response following diffuse axonal injuryMultimodal invasive monitoring in status epilepticus: what is the evidence it has a place?Role of Microvascular Disruption in Brain Damage from Traumatic Brain InjuryEmerging Roles for the Immune System in Traumatic Brain InjuryThe HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary DysfunctionInflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokinesThe neuroprotective functions of transforming growth factor beta proteinsThe far-reaching scope of neuroinflammation after traumatic brain injury.Overview of Traumatic Brain Injury: An Immunological ContextAnalysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.Role of microglia in a mouse model of paediatric traumatic brain injuryIsolated Brain Trauma in Cats Triggers Rapid Onset of HypovolemiaChronic post-traumatic headache: clinical findings and possible mechanisms.Critical Evaluation of the Lund Concept for Treatment of Severe Traumatic Head Injury, 25 Years after Its IntroductionTraumatic brain injury reveals novel cell lineage relationships within the subventricular zone.IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study.Interacting chemokine signals regulate dendritic cells in acute brain injuryPrincipal component analysis of the cytokine and chemokine response to human traumatic brain injury.Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.Brain microdialysis as a tool to explore the ionic profile of the brain extracellular space in neurocritical patients: a methodological approach and feasibility study.Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury.Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.Early brain injury after aneurysmal subarachnoid hemorrhage: a multimodal neuromonitoring study.Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in pigletsPost-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injuryLateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats.The cytokine temporal profile in rat cortex after controlled cortical impact.Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury.Osthole confers neuroprotection against cortical stab wound injury and attenuates secondary brain injuryGuilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injuryA pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agentRANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients
P2860
Q26740509-EB5F89CA-C3EE-4DD0-8EA5-95ACD50CEDBFQ26801688-DCB5BE9F-A5F8-42BF-A74D-404078F839E8Q26830132-28548941-325A-4D42-80F4-C03284EAFC04Q26851317-F9DAE849-567B-4898-9D6A-04FE82CC7524Q26860703-4F51D90D-088D-4201-B14E-7A97171F349EQ26998915-7B6702DD-2BFE-4AC7-9195-A7441389161FQ27009187-80FC928D-4DC2-45A0-B1C8-E40B877A98C9Q28071271-C3C376CE-83BC-4788-9F17-42C64361D393Q28085089-0F5B83FD-1BC4-4E09-895C-2F1FD7A5A39DQ28088301-F5E2A861-1E0A-45E1-B1EC-3A098E3F96C1Q28274093-B8D0B31A-70B4-4B17-956C-A05C92EA58B5Q30235977-808CBAEC-653B-492E-9D44-C1A610723571Q30238775-DDE303FB-9019-4FCE-92E0-3DFAC395D3ECQ30360306-EFE94E63-E60F-45DD-B4C1-8CAFADC19142Q33581165-EC65FDB9-6ABD-4A6B-84C6-F4AE7021D873Q33718924-771123A6-3C3E-4C54-8A73-457E640AA8A3Q33726057-4F80C0F5-46C9-4C04-BEBF-EA3613E39CFAQ33773248-A73ED7FB-67C1-4BE5-9E2D-94F1E55D2205Q33867530-D0FA1C90-515B-44AC-99B2-34787EF854EFQ33897633-135151C3-5F29-4384-83C9-B3B87DED9EB2Q33934678-9CCF7FF5-5767-435D-8997-C1E458277FD2Q34083673-74EE6408-2188-4F41-B894-2C3813FAB706Q34321617-FAE646C6-FBDF-4741-B230-3B3180BC068AQ34570859-2EDDE466-A5E9-465F-8CBB-154F719935A4Q34671588-A0D9468E-DBE1-400F-B428-437A10F572B9Q34674936-9EF6EAF2-BB2B-4815-B116-838B4083AFC0Q34751542-AB7FD43D-5645-47B9-BA87-461E1176FD3DQ34783240-75EFBEA8-754A-4D3A-B5DF-EF157B3D72F2Q35126001-EBC5AA42-7DA5-40B0-A666-68754B745DE2Q35257606-7C69C255-F839-4386-9B74-D39ACFF11C84Q35504074-CD7A16E0-6190-4113-94BE-0BE92EF6E8FAQ35549686-DA7E7640-A0BC-45B5-9C30-BAA033DA9D11Q35595627-D3D6C400-8B16-4F0E-BD9D-4D84D569F35DQ35694189-5705DA83-636B-4370-9AEC-D37666FD8188Q35863912-9695B676-CE29-415A-8268-4DAD7B1A7BFBQ35903835-7BADE494-D46F-4258-9EF0-D83C26024F0AQ36024014-608D75F3-4921-45EB-B902-20EBBFE8B74BQ36026673-4A66570B-0FDA-49C7-BF74-68E1F8DE0131Q36090064-F440EE90-B5C3-491C-BAF8-2630DDB92A8DQ36322531-FBA358A0-E820-46D7-8DB4-24872F689B71
P2860
The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The cytokine response to human ...... rebral parenchymal production.
@ast
The cytokine response to human ...... rebral parenchymal production.
@en
The cytokine response to human ...... rebral parenchymal production.
@nl
type
label
The cytokine response to human ...... rebral parenchymal production.
@ast
The cytokine response to human ...... rebral parenchymal production.
@en
The cytokine response to human ...... rebral parenchymal production.
@nl
prefLabel
The cytokine response to human ...... rebral parenchymal production.
@ast
The cytokine response to human ...... rebral parenchymal production.
@en
The cytokine response to human ...... rebral parenchymal production.
@nl
P2093
P2860
P356
P1476
The cytokine response to human ...... erebral parenchymal production
@en
P2093
David K Menon
John D Pickard
Peter J A Hutchinson
P2860
P304
P356
10.1038/JCBFM.2010.142
P577
2010-08-18T00:00:00Z